Literature DB >> 8124516

Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.

P J Larsen1, S P Sheikh, C R Jakobsen, T W Schwartz, J D Mikkelsen.   

Abstract

Using monoiodinated radioligands of peptide YY (PYY), and the recently introduced neuropeptide Y (NPY) analogue [Leu31, Pro34]NPY, receptor binding sites of the Y1 and Y2 type were localized in the rat brain by quantitative in vitro autoradiography. The binding specificity and affinity of both radiolabelled ligands were analysed by ligand binding studies employing rat brain membrane homogenates from cerebral cortex and hippocampus. Using in situ hybridization histochemistry, the regional distribution and cellular localization of mRNA encoding the Y1 receptor were investigated in rat brain sections and compared to the distribution of Y1-specific binding sites. PYY binds to both Y1 and Y2 receptors, while long C-terminal fragments such as NPY13-36 and NPY-16-36 bind preferentially to Y2 receptors. [Leu31,Pro34]NPY is a specific agonist for Y1 receptors. Highest densities of [125I]PYY binding sites were found in the cerebral cortex, the thalamus, the lateral septum, the hippocampus and the mesencephalic dopaminergic areas. In order to block putative Y2 receptors, a series of [125I]PYY binding experiments was performed in the presence of NPY13-36 (1 microM), a Y2 preferring C-terminal fragment. High densities of binding sites remained present in the cerebral cortex, the thalamus and the medial mammillary nucleus when NPY13-36 was present in the incubation medium. Furthermore, these areas were highly enriched with [125I][Leu31,Pro34]NPY binding sites. In contrast, the hippocampal complex had its binding capacity reduced by approximately 50%, while the lateral septum and mesencephalic dopaminergic areas had their binding capacities reduced even further. Linear regression analysis showed a high degree of correspondence between [125I][Leu31,Pro34]NPY binding and that obtained with [125I]PYY in the presence of 1 microM NPY13-36, suggesting that the two independent approaches to visualizing Y1 binding sites are comparable. In situ hybridization histochemistry revealed high levels of Y1 mRNA in the granular cell layer of the hippocampal dentate gyrus, several thalamic nuclei and the hypothalamic arcuate nucleus. Moderate levels of Y1 mRNA were seen in the frontoparietal cortex, several thalamic nuclei, the hippocampal pyramidal layers, the subiculum, the olfactory tubercle, the claustrum and a number of hypothalamic nuclei. The mesencephalon, the amygdala and most basal ganglia showed very low levels of hybridization. The present study further clarifies the anatomical distribution of multiple NPY binding sites within the central nervous system of the rat, and extends earlier suggestions that Y1 and Y2 receptor types are present within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8124516     DOI: 10.1111/j.1460-9568.1993.tb00231.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  16 in total

1.  Conservation of expression of neuropeptide Y5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control.

Authors:  K A Nichol; A Morey; M H Couzens; J Shine; H Herzog; A M Cunningham
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

2.  [(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors.

Authors:  Y Dumont; R Quirion
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

3.  Differential modulation of synaptic transmission by neuropeptide Y in rat neocortical neurons.

Authors:  Alberto Bacci; John R Huguenard; David A Prince
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

4.  Molecular alterations in areas generating fast ripples in an animal model of temporal lobe epilepsy.

Authors:  Kellen D Winden; Anatol Bragin; Jerome Engel; Dan H Geschwind
Journal:  Neurobiol Dis       Date:  2015-03-25       Impact factor: 5.996

5.  Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease.

Authors:  M Diez; J Koistinaho; S J Dearmond; D Groth; S B Prusiner; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

6.  Neuropeptide Y in central control of feeding and interactions with orexin and leptin.

Authors:  M Niimi; M Sato; T Taminato
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

7.  Role of the Y5 neuropeptide Y receptor in limbic seizures.

Authors:  D J Marsh; S C Baraban; G Hollopeter; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

8.  Knock-out mice reveal a critical antiepileptic role for neuropeptide Y.

Authors:  S C Baraban; G Hollopeter; J C Erickson; P A Schwartzkroin; R D Palmiter
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

9.  Localization of neuropeptide Y Y1 receptors in the rat nervous system with special reference to somatic receptors on small dorsal root ganglion neurons.

Authors:  X Zhang; L Bao; Z Q Xu; J Kopp; U Arvidsson; R Elde; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

10.  Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.

Authors:  Yvan Dumont; Mira Thakur; Annette Beck-Sickinger; Alain Fournier; Rémi Quirion
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.